These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3935873)

  • 21. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    ; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
    J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU.
    Shepard KV; Faintuch J; Bitran JD; Sweet DL; Robin E; Levin B
    Cancer Treat Rep; 1985 Jan; 69(1):123-4. PubMed ID: 4038471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma. A comparative trial with 6-thioguanine.
    Presant CA; Denes AE; Liu C; Bartolucci AA
    Cancer; 1984 Jun; 53(12):2610-4. PubMed ID: 6372981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.
    de Gramont A; Vignoud J; Tournigand C; Louvet C; André T; Varette C; Raymond E; Moreau S; Le Bail N; Krulik M
    Eur J Cancer; 1997 Feb; 33(2):214-9. PubMed ID: 9135491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.
    Arkenau HT; Rettig K; Porschen R
    Int J Colorectal Dis; 2005 May; 20(3):258-61. PubMed ID: 15549327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy of cisplatin and 5-FU in advanced colorectal carcinoma.
    Dy C; Gil A; Algarra SM; Aparicio LA; Calvo F; Herranz P
    Cancer Treat Rep; 1986 Apr; 70(4):465-8. PubMed ID: 3698039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of advanced-stage colorectal adenocarcinoma with fluorouracil and high-dose leucovorin calcium: a pilot study.
    Hines JD; Zakem MH; Adelstein DJ; Rustum YM
    J Clin Oncol; 1988 Jan; 6(1):142-6. PubMed ID: 3257256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term, ambulatory, continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas.
    Caballero GA; Ausman RK; Quebbeman EJ
    Cancer Treat Rep; 1985 Jan; 69(1):13-5. PubMed ID: 3155649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study.
    Grage TB; Vassilopoulos PP; Shingleton WW; Jubert AV; Elias EG; Aust JB; Moss SE
    Surgery; 1979 Oct; 86(4):550-5. PubMed ID: 384574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in patients with advanced colorectal cancer: Taiwan experience.
    Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Chen WS; Jiang JK; Yen CC; Fan FS; Hsieh RK
    Jpn J Clin Oncol; 1998 Jan; 28(1):16-9. PubMed ID: 9491136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group.
    Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; MacKay JR; Joseph D; Bell A; Goldstein D
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):883-7. PubMed ID: 11429215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preoperative treatment with 5-fluorouracil (5-FU) in gastric and colorectal cancer].
    Kawaura Y; Ohmura K; Hashizume Y; Takayama K; Sakatoku M; Hirano M; Yamada T; Iwa T
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):348-52. PubMed ID: 3970555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irinotecan (CPT11) plus high-dose 5-fluorouracil (5-FU) and leucovorin (LV) as salvage therapy for metastatic colorectal cancer (MCRC) after failed oxaliplatin plus 5-FU and LV: a pilot study in Taiwan.
    Tai CJ; Liu JH; Chen WS; Lin JK; Wang WS; Yen CC; Chiou TJ; Chen PM
    Jpn J Clin Oncol; 2003 Mar; 33(3):136-40. PubMed ID: 12672791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
    Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
    Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL
    Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405
    [No Abstract]   [Full Text] [Related]  

  • 37. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer.
    Sugarbaker PH; Gianola FJ; Speyer JC; Wesley R; Barofsky I; Meyers CE
    Surgery; 1985 Sep; 98(3):414-22. PubMed ID: 3898450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer.
    Garufi C; Lévi F; Aschelter AM; Pace R; Giunta S; Nisticò C; Gallà DA; Silecchia GF; Franchi F; Narduzzi C; Terzoli E
    Eur J Cancer; 1997 Sep; 33(10):1566-71. PubMed ID: 9389916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.
    Gamelin E; Boisdron-Celle M; Delva R; Regimbeau C; Cailleux PE; Alleaume C; Maillet ML; Goudier MJ; Sire M; Person-Joly MC; Maigre M; Maillart P; Fety R; Burtin P; Lortholary A; Dumesnil Y; Picon L; Geslin J; Gesta P; Danquechin-Dorval E; Larra F; Robert J
    J Clin Oncol; 1998 Apr; 16(4):1470-8. PubMed ID: 9552054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
    Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
    Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.